24 November 2022>: Clinical Research
Multiple Cytokine Analysis of Th1/Th2/Th9/Th17/Th22/Treg Cytokine Pathway for Individual Immune Profile Assessment in Patients with Psoriasis
Anna Michalak-Stoma 1ABCDEF* , Joanna Bartosińska 2ABCDEF , Dorota Raczkiewicz 3BCDEF , Małgorzata Kowal 1ABCDE , Joanna Kozak 4BCDE , Mariusz Gujski 5CDEF , Dorota Krasowska 1ACDEF , Grażyna Chodorowska 1ADEFDOI: 10.12659/MSM.938277
Med Sci Monit 2022; 28:e938277
Table 1 The characteristic of the study groups.
Variable | Psoriatic patients | Control group | ||
---|---|---|---|---|
Mean±SD | Min-Max | Mean±SD | Min-Max | |
Age (years) | 45.9±15.0 | 21.0–76.0 | 44.8±11.8 | 28.0–75.0 |
BMI | 27.4±5.3 | 20.0–46.1 | 24.25±3.0 | 20.0–32.8 |
Age of psoriasis onset (years) | 25.2±13.6 | 1.0–71.0 | ||
Duration of psoriasis (years) | 20.7±13.0 | 1.0–55.0 | ||
PASI | 15.3±10.1 | 3.0–43.2 | ||
PGA | 3.2±0.9 | 2.0–5.0 | ||
BSA (%) | 25.1±19.9 | 2.0–75.0 | ||
DLQI | 13.9±7.5 | 1.0–30.0 | ||
NAPSI | 20.4±16.0 | 0.0–64.0 |